• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Business/Financial News

DelCath closes $8m rights offering

September 28, 2018 By Fink Densford

Delcath Systems

Delcath Systems (NSDQ:DCTH) said yesterday it closed a previously announced rights offering bringing in approximately $8.1 million. The New York-based company said that it received approximately 4.3 million basic subscriptions and 418,207 oversubscriptions for a total of approximately 4.7 million subscriptions. Each subscription equates to a single share of Delcath’s common stock, the company said, with […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Delcath Systems Inc.

Gerresheimer’s Sensile Medical wins CE Mark for infusion pump

September 27, 2018 By Fink Densford

Gerresheimer's Sensile Medical

Gerresheimer subsidiary Sensile Medical said today it won CE Mark approval in the European Union for its wearable micropump intended for use in the treatment of Parkinson’s disease. The newly cleared device features automatic filling for use with liquid medicines, and includes a color display, charging unit and leather bag which allows the device to be worn […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Regulatory/Compliance Tagged With: gerresheimer, sensilemedical

Medtronic joins initiative to bring more women into the board room

September 17, 2018 By Sarah Faulkner

Medtronic logo updated

Medtronic (NYSE:MDT) said today that it joined the Catalyst CEO Champions For Change initiative, pledging to add more women to its executive team and board of directors. The medtech titan teamed up with global nonprofit Catalyst and promised that it would “strengthen the pipeline of women” within the organization using annual reviews and data tracking. Get […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Medtronic

Novocure inks Chinese collaborative deal with Zai Lab

September 12, 2018 By Fink Densford

Novocure

Novocure (NSDQ:NVCR) said today it inked a $15 million licensing agreement with Shanghai-based biopharma company Zai Lab to offer its Optune technology on the Chinese market and accelerate clinical trial enrollment in the region. The Optune device delivers low-intensity, intermediate frequency, alternating electric fields, called “Tumor Treating Fields,” to inhibit cancer cell replication. Through the agreement, Novocure granted […]

Filed Under: Business/Financial News, Oncology Tagged With: NovoCure

One Drop wirelessly connects to Apple Watch

September 12, 2018 By Nancy Crotti

One Drop

One Drop said today that its wireless blood glucose monitoring system can now connect directly to Apple Watch, making it the first diabetes company’s system to do so. One Drop was also the first such company to launch a companion Apple Watch app, but until now, users had to manually log blood glucose, food, medication, […]

Filed Under: Big Data, Business/Financial News, Diabetes, Technology, Uncategorized Tagged With: Apple, onedrop

PCI Pharma Services to buy Sherpa Clinical Packaging

September 11, 2018 By Chris Newmarker

PCI Pharma Services has agreed to acquire clinical supply services provider Sherpa Clinical Packaging, the companies announced today. Financial terms of the deal were not disclosed. San Diego–based Sherpa is a provider of clinical trial material management services for clinical studies phases I through IV, with expertise in packaging, labeling, distribution, storage and returns and […]

Filed Under: Business/Financial News, Clinical Trials, Contract Services, Featured, Mergers & Acquisitions, Pharmaceuticals Tagged With: pcipharmaservices, sherpaclinicalpackaging

Cook, AcuityBio ink deal for lung cancer drug technology

September 6, 2018 By Nancy Crotti

Cook Biotech will collaborate with drug-delivery maker AcuityBio on Acuity’s lead lung cancer product, the companies said today. Acuity’s ABC103 will use Cook Biotech’s proprietary extracellular matrix (ECM) technology. ABC103 is a platform technology designed for localized, sustained drug delivery to prevent post-surgical lung cancer recurrence. It combines approved/ cleared surgical staple-line buttress, drug-eluting polymers and […]

Filed Under: Business/Financial News, Drug-Device Combinations, Food & Drug Administration (FDA), Oncology Tagged With: acuitybio, cookbiotech, FDA

Fujifilm backs therapeutic administration dev Suono Bio

September 5, 2018 By Fink Densford

Suono Bio

Suono Bio said today that Fujifilm (TSE:4901) made an undisclosed investment in the company to support its next-gen technology intended for the rapid, formulation-independent administration of therapeutics. The Cambridge, Mass.-based company, formed last year by researchers out of the Massachusetts Institute of Technology and Brigham & Women’s Hospital, is developing technology intended for the rapid local administration of […]

Filed Under: Business/Financial News, Research & Development Tagged With: Fujifilm Holdings, suonobio

Livongo adds compatibility with Abbott’s FreeStyle Libre Pro

September 5, 2018 By Fink Densford

Livongo, Abbott

Livongo Health said today it will integrate continuous glucose data from Abbott‘s (NYSE:ABT) FreeStyle Libre Pro system into its Livongo for Diabetes system, touting it as the first such system to integrate data from Abbott’s FreeStyle Libre Pro. With the integration, users of the FreeStyle Libre Pro will be able to see a visual snapshot of […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: abbott, livongohealth

Exosome therapeutics dev Evox raises $45m in Series B

September 4, 2018 By Fink Densford

Evox Therapeutics

Exosome therapeutics company Evox Therapeutics said today that it raised $45.4 million (GBP £35.5 million) in a Series B round of financing. The funding round was led by Redmile Group, new investments from GV, formerly known as Google Ventures, and Cowen Healthcare Investments, the Oxford, U.K.-based company said. The round was joined by Panacea Healthcare […]

Filed Under: Business/Financial News, Featured, Funding Roundup Tagged With: evoxtherapeutics

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 71
  • Go to page 72
  • Go to page 73
  • Go to page 74
  • Go to page 75
  • Interim pages omitted …
  • Go to page 92
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS